Pathology: la/mBC - HR positive - L1 - PIK3CA mutant; mBC - TNBC - L1 - all population;
| la/mBC - HR positive - L1 - PIK3CA mutant | mBC - TNBC - L1 - all population | ||
| IPATunity130, 2022 | LOTUS, 2017 | ||
| ipatasertib plus paclitaxel | 2 | T1 | T1 |
| paclitaxel | 0 | T0 | |
| Standard of Care (SoC) | 0 | T0 |